Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · June 25, 2013

Efficacy and Safety of Ustekinumab in Active Psoriatic Arthritis

The Lancet

 

Additional Info

The Lancet
Efficacy and Safety of Ustekinumab in Patients With Active Psoriatic Arthritis: 1 Year Results of the Phase 3, Multicentre, Double-Blind, Placebo-Controlled PSUMMIT 1 Trial
Lancet 2013 Jun 13;[EPub Ahead of Print], IB McInnes, A Kavanaugh, AB Gottlieb, L Puig, P Rahman, C Ritchlin, C Brodmerkel, S Li, Y Wang, AM Mendelsohn, MK Doyle

Further Reading